CRISPR Therapeutics
A biopharmaceutical and gene editing company founded in 2013. CRISPR Therapeutics AG is based in Zug, Switzerland and CRISPR Therapeutics, Inc. is the U.S. subsidiary with R&D operations in Cambridge, Massachusetts and business offices in London, U.K.
5
Funding Rounds
$127.0m
Money raised
Overview
A biopharmaceutical and gene editing company founded in 2013. CRISPR Therapeutics AG is based in Zug, Switzerland and CRISPR Therapeutics, Inc. is the U.S. subsidiary with R&D operations in Cambridge, Massachusetts and business offices in London, U.K.
| Name | Phone | Social networks | |
|---|---|---|---|
| Ro**** No*** | - | - | - |
| Sa***** Ku****** | - | - | linkedin twitter |
| Si**** J. Ge**** | - | - | - |
| Ka******* A. Hi** | - | - | |
| Ma*** Fa**** | - | - | - |
| Al* Be******* | - | - | |
| Jo** Gr**** | - | - |
Industries
CRISPR Therapeutics is active in the following industries:
- Cancer immunotherapy
- Genetic engineering
- Therapeutics
- Cell therapy
- Immunotherapy
- Biopharmaceutical
- Biomedical engineering
- Technology
- Biology
- Biotechnology
- Healthcare
- Regenerative medicine
- Internal medicine
- Oncology
- Genomics
- Genome editing
- Engineering
- Synthetic chemistry
